dr. reddy's labs glp-1 receptor agonists weight management diabetes treatments Laboratories has entered the fast-growing therapy segment with the launch of its semaglutide generic, Obeda, for Type 2 in India's โน1,446 crore market. ๐๐๐๐ ๐๐ฎ๐ฅ๐ฅ ๐๐ซ๐ญ๐ข๐๐ฅ๐ ๐จ๐ง ๐จ๐ฎ๐ซ ๐ฆ๐ฒ๐บ๐ฎ๐ด๐น๐๐๐ถ๐ฑ๐ฒ ๐๐ผ๐ฒ๐ ๐๐ฒ๐ป๐ฒ๐ฟ๐ถ๐ฐ ๐ถ๐ป ๐๐ป๐ฑ๐ถ๐ฎ:
Pay in 4 interest-free payments of $6.09 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours ยท Estimated delivery Oct 12 - Oct 17




























